Welcome to our dedicated page for Cryoport news (Ticker: CYRX), a resource for investors and traders seeking the latest updates and insights on Cryoport stock.
The Cryoport, Inc. (NASDAQ: CYRX) news page on Stock Titan aggregates company announcements, earnings releases, and operational updates related to its role in temperature-controlled supply chain solutions for the life sciences. Cryoport regularly issues news about its performance, infrastructure expansion, and developments across its Life Sciences Services and Life Sciences Products segments.
Recent news has highlighted quarterly financial results, including revenue from continuing operations across Life Sciences Services, BioStorage/BioServices, and Life Sciences Products. The company also reports on metrics such as the number of commercial cell and gene therapies it supports and the global clinical trials that rely on its logistics and storage capabilities.
Operational updates feature the launch and expansion of Global Supply Chain Centers, such as the facility near Paris Charles de Gaulle Airport, which is designed to provide end-to-end, temperature-controlled solutions for biopharma, animal health, and reproductive medicine. Additional news items cover product and technology introductions from MVE Biological Solutions, including dry vapor shippers and integrated condition monitoring systems powered by Tec4med, as well as the MVECloud platform for monitoring cryogenic environments.
Cryoport also publishes news on strategic actions, such as the divestiture of its CRYOPDP specialty courier business and its strategic partnership with DHL, and on quality and compliance milestones, including ISO 21973 certification for transportation of human cells for therapeutic use. Investors and industry observers can use this news feed to follow how Cryoport’s financial performance, infrastructure, and service offerings evolve over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Cryoport, Inc. (NASDAQ: CYRX) has announced it will release its financial results for the first quarter ending March 31, 2023, on May 4, 2023, after U.S. market close. Alongside the earnings, a detailed review titled 'Cryoport First Quarter 2023 in Review' will be provided at 4:05 PM ET that day. The company will host a conference call at 5:00 PM ET to discuss the results, with a live webcast available on its investor relations page. The call requires a confirmation code for access and will be recorded for later replay. Cryoport specializes in temperature-controlled supply chain solutions for life sciences, with a global reach across Americas, EMEA, and APAC regions.
Cryoport, Inc. (NASDAQ: CYRX) has entered a three-year agreement with Boston IVF, enhancing its temperature-controlled supply chain solutions for reproductive materials across multiple U.S. states, including Massachusetts and New York. This collaboration aims to improve shipment efficiency and mitigate risks for patients relying on Boston IVF's services. Boston IVF, with over 150,000 successful births since 1986, will benefit from Cryoport's advanced technology and continuous monitoring. Both companies emphasize their commitment to exceptional patient care, marking a significant step in Cryoport's strategic growth in the reproductive healthcare sector.